Published in Eur J Surg Suppl on July 01, 2003
Factors associated with posttraumatic stress symptoms in a prospective cohort of patients after abdominal sepsis: a nomogram. Intensive Care Med (2008) 1.07
Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma. Crit Care (2006) 1.04
Long-term prevalence of post-traumatic stress disorder symptoms in patients after secondary peritonitis. Crit Care (2007) 0.92
Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies. Crit Care (2016) 0.89
Incidence and long-term outcome of sepsis on general wards and in an ICU at the General Hospital of Vienna: an observational cohort study. Wien Klin Wochenschr (2013) 0.89
Organ dysfunction and long term outcome in secondary peritonitis. Langenbecks Arch Surg (2007) 0.89
Health related quality of life six months following surgical treatment for secondary peritonitis--using the EQ-5D questionnaire. Health Qual Life Outcomes (2007) 0.81
Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis. World J Surg (2009) 0.80
NF-kappaB activation and inhibition: a review. Shock (2002) 1.55
Gastrointestinal complications after cardiac surgery - improved risk stratification using a new scoring model. Interact Cardiovasc Thorac Surg (2009) 1.43
The handling of peripheral venous catheters--from non-compliance to evidence-based needs. J Clin Nurs (2010) 1.39
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity. J Clin Oncol (2013) 1.30
Identification of serum biomarker signatures associated with pancreatic cancer. Cancer Res (2012) 1.27
Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol (2010) 1.14
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? World J Gastroenterol (2012) 1.12
Immune status and inflammatory response differ locally and systemically in severe acute pancreatitis. Scand J Gastroenterol (2006) 1.09
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. BMC Cancer (2013) 1.07
Single-institution experience with solid pseudopapillary neoplasm of the pancreas. Scand J Gastroenterol (2011) 1.07
Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology (2011) 1.06
Fluid resuscitation and nutritional support during severe acute pancreatitis in the past: what have we learned and how can we do better? Clin Nutr (2005) 1.05
Compromise of immune function in obstructive jaundice. Eur J Surg (2002) 1.01
Late abdominal complaints after appendectomy--readmissions during long-term follow-up. Dig Surg (2003) 1.01
Fast-track programmes for hepatopancreatic resections: where do we stand? HPB (Oxford) (2011) 1.01
Percutaneous cholecystostomy: a bridge to surgery or definite management of acute cholecystitis in high-risk patients? Scand J Gastroenterol (2008) 1.00
Fast-track surgery: procedure-specific aspects and future direction. Langenbecks Arch Surg (2012) 0.99
Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharmacol (2005) 0.99
Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. World J Gastroenterol (2012) 0.95
Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol (2007) 0.95
Enrichment of murine CD68+ CCR2+ and CD68+ CD206+ lung macrophages in acute pancreatitis-associated acute lung injury. PLoS One (2012) 0.92
Artificial neural networks predict survival from pancreatic cancer after radical surgery. Am J Surg (2013) 0.91
Severe acute pancreatitis--outcome following a primarily non-surgical regime. Pancreatology (2006) 0.91
Non-operative management of blunt liver trauma: feasible and safe also in centres with a low trauma incidence. HPB (Oxford) (2009) 0.90
Potential effects of peroxisome proliferator-activated receptor activator on LPS-induced lung injury in rats. Pulm Pharmacol Ther (2009) 0.89
SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer. Pancreas (2015) 0.88
TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated. J Transl Med (2011) 0.87
The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats. Scand J Gastroenterol (2010) 0.87
Potential role of reactive oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology (2005) 0.87
Role of nuclear factor-kappaB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis. Scand J Gastroenterol (2005) 0.86
Influence of mast cells on the expression of adhesion molecules on circulating and migrating leukocytes in acute pancreatitis-associated lung injury. Lung (2005) 0.86
Initiation of acute pancreatitis by heparan sulphate in the rat. Scand J Gastroenterol (2008) 0.86
Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. J Surg Res (2002) 0.86
Management of appendiceal masses. Eur J Surg (2002) 0.86
Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach. World J Surg (2011) 0.85
Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury. Exp Biol Med (Maywood) (2013) 0.85
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int J Cancer (2013) 0.84
Varying susceptibility of pulmonary cytokine production to lipopolysaccharide in mice. Cytokine (2009) 0.84
Pancreatic cancer - cost for overtreatment with gemcitabine. Acta Oncol (2012) 0.84
Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction. Pancreatology (2002) 0.83
Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg (2012) 0.83
Proteomics and leukocytes: an approach to understanding potential molecular mechanisms of inflammatory responses. J Proteome Res (2004) 0.83
Treatment and outcome in pancreatic pseudocysts. Scand J Gastroenterol (2006) 0.83
Survey of the management of pancreatic pseudocysts in Sweden. Scand J Gastroenterol (2009) 0.83
Potential effects of PKC or protease inhibitors on acute pancreatitis-induced tissue injury in rats. Vascul Pharmacol (2007) 0.83
Pancreatic cancer: translational research aspects and clinical implications. World J Gastroenterol (2012) 0.83
Treatment with anti-factor VIIa in acute pancreatitis in rats: blocking both coagulation and inflammation? Scand J Gastroenterol (2007) 0.83
Proteome-based biomarkers in pancreatic cancer. World J Gastroenterol (2011) 0.83
Acute lung injury in acute pancreatitis--awaiting the big leap. Respir Med (2012) 0.82
Prediction of severe acute pancreatitis at admission to hospital using artificial neural networks. Pancreatology (2011) 0.82
Establishment and assessments of a new model for the postoperative fatigue syndrome by major small intestinal resection in rats. Scand J Gastroenterol (2011) 0.82
Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice. Respir Physiol Neurobiol (2010) 0.82
The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer. Pancreatology (2011) 0.82
The role of SPARC expression in pancreatic cancer progression and patient survival. Scand J Gastroenterol (2015) 0.82
Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model. PLoS One (2012) 0.81
Proposed protective mechanism of the pancreas in the rat. J Inflamm (Lond) (2010) 0.81
Long-term follow-up for adhesive small bowel obstruction after open versus laparoscopic surgery for suspected appendicitis. Ann Surg (2014) 0.81
Controversial role of toll-like receptors in acute pancreatitis. World J Gastroenterol (2013) 0.81
Pancreatic function, quality of life and costs at long-term follow-up after acute pancreatitis. World J Gastroenterol (2010) 0.81
Prevention of postoperative peritoneal adhesions: effects of lysozyme, polylysine and polyglutamate versus hyaluronic acid. Scand J Gastroenterol (2005) 0.80
Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford) (2013) 0.80
Intraoperative radiotherapy for patients with carcinoma of the pancreas. Pancreatology (2005) 0.80
Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures. Proteomics Clin Appl (2012) 0.80
Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Scand J Gastroenterol (2013) 0.80
Cystic pancreatic lesions: current evidence for diagnosis and treatment. Scand J Gastroenterol (2011) 0.80
Acute pancreatitis, expression of inducible nitric oxide synthase and defective insulin secretion. Cell Tissue Res (2003) 0.80
Efficacy of bioactive polypeptides on bleeding and intra-abdominal adhesions. Eur Surg Res (2007) 0.79
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. J Cancer Res Clin Oncol (2014) 0.79
Lactobacilli attenuate bacteremia and endotoxemia associated with severe intra-abdominal infection. Surgery (2003) 0.79
Chronic pancreatitis: potential future interventions. Scand J Gastroenterol (2010) 0.79
Fast-track program for liver resection--factors prolonging length of stay. Hepatogastroenterology (2015) 0.79
Oral traditional Chinese medication for adhesive small bowel obstruction. Cochrane Database Syst Rev (2012) 0.79
Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection. Scand J Gastroenterol (2012) 0.79
Clinical impact of abdominal adhesions: what is the magnitude of the problem? Scand J Gastroenterol (2008) 0.79
Acute pancreatitis--costs for healthcare and loss of production. Scand J Gastroenterol (2013) 0.79
The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM). Clin Transl Med (2012) 0.79
Repeated Liver Resection for Colorectal Liver Metastases: A Comparison with Primary Liver Resections concerning Perioperative and Long-Term Outcome. Gastroenterol Res Pract (2012) 0.79
Differently charged polypeptides in the prevention of post-surgical peritoneal adhesions. Scand J Gastroenterol (2007) 0.78
Development and promotion in translational medicine: perspectives from 2012 sino-american symposium on clinical and translational medicine. Clin Transl Med (2012) 0.78
Experimental studies on treatment of pancreatic cancer with double-regulated duplicative adenovirus AdTPHre-hEndo carrying human endostatin gene. Pancreatology (2013) 0.78
Surgical stress response after colorectal resection. Int Surg (2013) 0.78
Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition. Pancreatology (2012) 0.78
Protein kinase C modulates the pulmonary inflammatory response in acute pancreatitis. Respir Physiol Neurobiol (2005) 0.78
Antibiotics versus surgery for appendicitis. Lancet (2011) 0.78
[Appendicitis--after the diagnostics. Focusing on the diagnostics has pushed the disease management into the background]. Lakartidningen (2004) 0.78
Increasing anastomosis safety and preventing abdominal adhesion formation by the use of polypeptides in the rat. Int J Colorectal Dis (2005) 0.77
Importance of thrombocytes for the hypertrophy response after portal vein embolization. Hepatogastroenterology (2015) 0.77
Fatal acute pancreatitis occurring outside of the hospital: clinical and social characteristics. World J Surg (2010) 0.77
Potential mechanisms and significance of acute pancreatitis-associated liver injury. Scand J Gastroenterol (2006) 0.77
Active site-inactivated factor VIIa inhibits nuclear factor kappa B activation in intestinal ischemia and reperfusion. J Surg Res (2012) 0.77
The effects of 5-fluorouracil on severe acute pancreatitis-inducing apoptosis of macrophages. Pancreas (2014) 0.77
The efficiency of continuous regional intra-arterial infusion in the treatment of infected pancreatic necrosis. Pancreatology (2013) 0.77
Liver ischaemia following vascular occlusion: a century's experience. Scand J Gastroenterol (2008) 0.77
Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges. Lung (2005) 0.77
CODUSA--customize optimal donor using simulated annealing in heart transplantation. Sci Rep (2013) 0.77
Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases. Scand J Gastroenterol (2012) 0.77
Radioimmunotherapy--a potential novel tool for pancreatic cancer therapy? Tumour Biol (2015) 0.77
Solitary liver lesions of indeterminate malignancy--outcome following surgical resection. Anticancer Res (2012) 0.77
Survey of the management of acute pancreatitis in surgical departments in Sweden. Scand J Gastroenterol (2012) 0.76